Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:32 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 998 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Comparison control condition Clear all

Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Obesity
Interventions: Metabolic surgery, Incretin-Based Therapy; Procedure · Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 4
States / cities: Phoenix, Arizona • Indianapolis, Indiana • Rochester, Minnesota + 1 more

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: GSK5784283, Placebo, Standard of care; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 8
States / cities: Cape Coral, Florida • Greenacres City, Florida • Miami, Florida + 5 more

Conditions: Pregnancy Prevention, Life Skill Development
Interventions: Healthy Adolescent Transitions (HAT) program; Behavioral
Lead sponsor: Jack Stevens; Other
Eligibility: 14 Years to 19 Years · Female only
Enrollment: 331 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Osteopenia
Interventions: Oral calcitonin at dinnertime, Oral placebo at dinnertime, Oral calcitonin at bedtime, Oral placebo at bedtime; Drug
Lead sponsor: Tarsa Therapeutics, Inc.; Industry
Eligibility: 45 Years and older · Female only
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 10
States / cities: Walnut Creek, California • Clearwater, Florida • Bethesda, Maryland + 7 more

Conditions: Diabetes, Prediabetes
Interventions: SCT-based Resistance Training exercise program, Standard Intervention with minimal contact; Behavioral · Other
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 50 Years to 69 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Blacksburg, Virginia • Roanoke, Virginia

Conditions: Generalized Anxiety Disorder
Interventions: Applied relaxation and self-control desensitization, Cognitive therapy (CT), Cognitive-Behavioral Therapy; Behavioral · Other
Lead sponsor: Michelle G. Newman; Other
Eligibility: 18 Years to 85 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 1998
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Breast Cancer, Obesity
Interventions: Group phone counseling, Newsletter; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: Up to 75 Years · Female only
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Sickle Cell Disease, Vaso-occlusive Crisis
Interventions: Patient controlled analgesia, nurse-administered intermittent IV bolus opioid therapy (NAIBOD); Procedure · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sickle Cell Disease, Vaso-Occlusive Crisis
Interventions: Ketamine; Drug
Lead sponsor: UCSF Benioff Children's Hospital Oakland; Other
Eligibility: 10 Years to 25 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Oakland, California

Conditions: Pain, Chronic Pain, Mental Disorders, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Arthritis
Interventions: Unblinded to Genetic Testing Results, Blinded to Genetic Testing Results; Other
Lead sponsor: Proove Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 31
States / cities: Beverly Hills, California • Fresno, California • La Jolla, California + 23 more

Conditions: Physical Activity
Interventions: SMART Behavioral Group, SMART Informational Group; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 13 Years to 15 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucous Carcinoma, Stage 0 Lip and Oral Cavity Cancer, Tongue Cancer
Interventions: fluorescence imaging, biopsy, examination, Comparison of surgical margins by COE vs. DVFE; Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Drinking and Driving
Interventions: BAC feedback/warning, No BAC feedback/warning; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 21 Years to 35 Years
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: EXPD-101/FXS7553 Dose 1, EXPD-101/FXS7553 Dose 2, Placebo; Drug
Lead sponsor: Expedition Therapeutics, Inc; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 29
States / cities: Phoenix, Arizona • Encino, California • Northridge, California + 26 more

Conditions: Rheumatoid Arthritis, Myositis, Osteoarthritis, Weakness, Muscle
Interventions: Strength Training; Other
Lead sponsor: Louisiana State University Health Sciences Center Shreveport; Other
Eligibility: 18 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Shreveport, Louisiana

Conditions: Dry Eye Disease
Interventions: Varenicline solution, Placebo nasal spray (OC-01 Vehicle Nasal Spray); Drug
Lead sponsor: Stephenson Eye Associates; Other
Eligibility: 22 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Venice, Florida

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Once-daily aclidinium/formoterol, Twice-daily formoterol fumarate, Placebo to formoterol fumarate, Once-daily formoterol fumarate; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 40
States / cities: Tucson, Arizona • Fullerton, California • Lakewood, California + 36 more

Conditions: Human Papillomavirus Virus, HPV
Interventions: Web App Intervention Group, Usual Customary Care Group; Behavioral
Lead sponsor: Klein Buendel, Inc.; Industry
Eligibility: 11 Years and older
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 3
States / cities: Golden, Colorado • Indianapolis, Indiana • Albuquerque, New Mexico

Conditions: Insomnia, Sleeplessness
Interventions: Wholetones Music, Classical Music; Behavioral
Lead sponsor: Jacksonville University; Other
Eligibility: 25 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Cancer, Alcohol Use
Interventions: TRAC: Tracking and Reducing Alcohol Consumption, No intervention; Behavioral · Other
Lead sponsor: Carolyn Lauckner; Other
Eligibility: 18 Years to 39 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Breast Neoplasms
Interventions: Xentuzumab, Placebo, Everolimus, Exemestane; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 16
States / cities: Chandler, Arizona • Goodyear, Arizona • Beverly Hills, California + 13 more

Conditions: Generalized Anxiety Disorder
Interventions: Quetiapine fumarate; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 876 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 58
States / cities: Springdale, Arizona • Little Rock, Arkansas • Encino, California + 55 more

Conditions: Pregnancy, Substance Use, Depression, Anxiety
Interventions: Listening to Women and Pregnant and Postpartum People; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 41 Years · Female only
Enrollment: 415 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Metastatic Neuroendocrine Tumor
Interventions: Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging, Triapine; Procedure · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 25
States / cities: Duarte, California • Irvine, California • Orange, California + 19 more

Search by objective public record fields.

Fibrosis Lessens After Metabolic Surgery

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Healthy Adolescent Transitions (HAT)

A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis

Maintaining Resistance Training in Older Prediabetic Adults

A Comparison Between Cognitive, Behavioral, and Cognitive-Behavioral Therapy for Generalized Anxiety Disorder

Rural Women Connecting for Better Health

Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC)

Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis

A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care

The Social Media and Activity Research in Teens Trial

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

Alcohol Impaired Driving: From the Laboratory to the Natural Environment

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations

Evaluation of Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray

Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake

Efficacy of Wholetones® 2Sleep Music on Health and Sleep Behaviors of Healthy Adults With Insomnia Symptoms

Evaluating an mHealth Intervention for Reducing Alcohol Use Among Adolescent and Young Adult Cancer Survivors

The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Pilot Randomized Controlled Trial (RCT): Remote SBIRT Vs. In-Person SBIRT

Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors